🇺🇸 FDA
Patent

US 11110139

Application of anthocyanin extract in preparing pharmaceutical composition for preventing and treating cardiac toxicity induced by anthracyclines and pharmaceutical composition

granted A61KA61K2236/333A61K36/185

Quick answer

US patent 11110139 (Application of anthocyanin extract in preparing pharmaceutical composition for preventing and treating cardiac toxicity induced by anthracyclines and pharmaceutical composition) held by Northwest Institute of Plateau Biology, Chinese Academy of Sciences expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwest Institute of Plateau Biology, Chinese Academy of Sciences
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2236/333, A61K36/185, A61P, A61P9/00